FDA issues labeling changes for testosterone products
The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products.
US FDA issues labeling changes for testosterone products
The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...
Kennedy proposes scrapping public comment on major US health policies
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. is seeking to eliminate public participation in many of his ...
California College Pushes Back on Damning Report About Plastics in Food
Stanford disputes a report claiming high plastic levels in dining hall food, launching its own investigation into ...
FDA allowed to help WHO update flu shots, despite Trump ban
The Food and Drug Administration was allowed to participate in the World Health Organization's meeting this week on updating ...
FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...
Vaccine meeting to prepare for coming winter’s flu season canceled
The meeting is the second federal vaccine panel meeting Trump administration officials have canceled or postponed since RFK ...
So Much For RFK, Jr.'s Promise of 'Radical Transparency' at HHS
RFK, Jr.'s Health and Human Service has inexplicably cancelled two vaccine-related advisory meetings since he took the helm ...
STAT12h
To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
With the right policies, advanced science, and strong leadership in government agencies, Donald Trump has the power to save ...
Pharm Exec3h
FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors
FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.
The American Journal of Managed Care3h
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...